Christina Flaxel, R. Samples John

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Metipranolol (Optipranololr̀) is a new ophthalmic nonselective beta-blocker introduced by Bausch and Lomb Pharmaceuticals. Its chemical name is metipranolol hydrochloride or 1-(4-hydroxy-2,3,5-trimethylphenoxy)-3(isopropylaninol)-2-pro-panolol 4-acetate. 1 It is marketed as a 0.3% solution and has the advantage of a decreased cost compared to the other commercially available beta blockers. It is indicated in the treatment of ocular conditions in which lowering intraocular pressure (IOP) is likely to be of therapeutic benefit: in patients with ocular hypertension and patients with chronic open angle glaucoma.

Original languageEnglish (US)
Pages (from-to)171-174
Number of pages4
JournalCutaneous and Ocular Toxicology
Issue number3
StatePublished - Jan 1 1991

ASJC Scopus subject areas

  • Toxicology


Dive into the research topics of 'Metipranolol'. Together they form a unique fingerprint.

Cite this